|
Volumn 6, Issue 2, 2004, Pages 105-107
|
Mining our ABCs: Pharmacogenomic approach for evaluating transporter function in cancer drug resistance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6 MERCAPTOPURINE DERIVATIVE;
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
CARRIER PROTEIN;
CISPLATIN;
DOXORUBICIN;
ESTRAMUSTINE;
ETOPOSIDE;
FLAVOPIRIDOL;
GLYCOPROTEIN P;
IMATINIB;
MERCAPTOPURINE;
METHOTREXATE;
METHYLTESTOSTERONE;
MITOXANTRONE;
MULTIDRUG RESISTANCE PROTEIN 1;
PACLITAXEL;
PROTEIN;
PROTEIN MDR2;
PYRIMIDINE NUCLEOTIDE;
TAXANE DERIVATIVE;
TENIPOSIDE;
TOPOTECAN;
UNCLASSIFIED DRUG;
VINBLASTINE;
VINCA ALKALOID;
CANCER;
CELL LINE;
DATA BASE;
DRUG RESPONSE;
DRUG SENSITIVITY;
DRUG TRANSPORT;
GENE MUTATION;
HUMAN;
MEDICAL INFORMATION;
NONHUMAN;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
QUANTITATIVE ANALYSIS;
REAL TIME POLYMERASE CHAIN REACTION;
SHORT SURVEY;
VALIDATION PROCESS;
CLASSIFICATION;
DRUG RESISTANCE;
EVALUATION;
GENE EXPRESSION PROFILING;
GENETICS;
METABOLISM;
NOTE;
PHARMACOGENETICS;
PHYSIOLOGY;
VINCA;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
EVALUATION STUDIES;
GENE EXPRESSION PROFILING;
HUMANS;
MEMBRANE TRANSPORT PROTEINS;
PHARMACOGENETICS;
|
EID: 5144226212
PISSN: 15356108
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ccr.2004.08.003 Document Type: Review |
Times cited : (36)
|
References (12)
|